Medicine
Tryptyr 0.03 mg/mL ophthalmic solution
Tryptyr 0.03 mg/mL ophthalmic solution is a prescription medicine containing Acoltremon for ophthalmic, topical use, marketed by Alcon Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F). If stored at room…
Key facts
- Active ingredient (INN)
- Acoltremon
- Brand
- Tryptyr
- Strength
- 0.03 mg/mL
- Dosage form
- Ophthalmic solution
- Route
- Ophthalmic, topical
- Packs
- 12 pouches
- Marketing authorisation holder
- Alcon Laboratories
- Manufacturer
- Alcon Laboratories
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F). If stored at room temperature, TRYPTYR should be used within 30 days, not to exceed the expiration date printed on the carton and foil pouch. After opening the carton, TRYPTYR may be stored refrigerated or at room temperature at 2°C to 25°C (36°F to 77°F). Store unopened single-dose vials in the original foil pouch until ready to use.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 July 2025
- Identifiers
- RxCUI 2716821, 2716826DailyMed set ID 2b7715a1-035c-4002-b582-5238efee5d58NDC 0065-8595Application NDA217370
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 pouch in 1 carton / 5 vial in 1 pouch / .4 mL in 1 vial | 0065-8595-02 | Alcon Laboratories | 23 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 May 2025 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Acoltremon is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease. It is available as ophthalmic solution for topical use. MedsAcross supplies Acoltremon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcoltremonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TRYPTYR prescribing information (Alcon Laboratories) · U.S. National Library of Medicine, DailyMed
Need Tryptyr 0.03 mg/mL ophthalmic solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.